首页 | 本学科首页   官方微博 | 高级检索  
     

肺癌新肿瘤标志物periplakin的筛选研究(英文)
引用本文:Shuqin Dai,Wei Li,Mian Kong,Yuzhen Zheng,Shuying Chen,Junye Wang,Linquan Zang. 肺癌新肿瘤标志物periplakin的筛选研究(英文)[J]. 中德临床肿瘤学杂志, 2013, 12(7): 305-309. DOI: 10.1007/s10330-013-1178-y
作者姓名:Shuqin Dai  Wei Li  Mian Kong  Yuzhen Zheng  Shuying Chen  Junye Wang  Linquan Zang
作者单位:Department of Clinical Laboratory,Sun Yat-sen University Cancer Center;State Key Laboratory of Oncology in Southern China;Department of Thoracic Surgery,Sun Yat-sen University Cancer Center;Department of Pharmacology,College of Pharmacy,Guangdong Pharmaceutical University
基金项目:grants,from,the,Science,and,Technology,Planning,Project,of,Guangdong,Province(项目编号:2010B031600066,,2010B031500034,2008B030303008)the,Key,Scientific,Subject,Foundation,of,Ministry,of,Education,of,China(项目编号:208105)the,NationalScience,and,Technology,Major,Projects,for,New,Drugs(项目编号:2011zx09102-001-31)
摘    要:Objective: The aim of this study was to use lung cancer targeting binding polypeptide ZS-9 to screen cDNA library of human lung cancer and obtain ZS-9 specific ligand to confirm tumor marker of non small-cell lung cancer. Methods: Artificially synthesize biotin labeled peptide ZS-9, anchored ZS-9 in the enzyme label plate coupled by avidin, used ZS-9 as probe to screen cDNA library of human lung cancer, after screening, obtained bacteriophage clone specifically binding with anchored polypeptide ZS-9. Extracted plasmid of bacteriophage and performed sequencing after amplified by PCR. Results: It was demonstrated by bioinformatic analysis on the sequence of ligand binded by lung cancer specific peptide ZS-9 that the ligand was the cytoskeletal protein periplakin on the surface of lung cancer cells, suggesting that periplakin might be a new marker for non-small-cell lung cancer in lung cancer. Conclusion: Use specific lung cancer binding peptide to screen new tumor marker periplakin in lung cancer and further studies on its biologic functions in genesis and development of lung cancer are still needed.

关 键 词:cDNA library  lung cancer  peptide  phage display  biomarker

Screening study on new tumor marker periplakin for lung cancer
Shuqin Dai,Wei Li,Mian Kong,Yuzhen Zheng,Shuying Chen,Junye Wang,Linquan Zang. Screening study on new tumor marker periplakin for lung cancer[J]. The Chinese-German Journal of Clinical Oncology, 2013, 12(7): 305-309. DOI: 10.1007/s10330-013-1178-y
Authors:Shuqin Dai  Wei Li  Mian Kong  Yuzhen Zheng  Shuying Chen  Junye Wang  Linquan Zang
Affiliation:11178. Department of Clinical Laboratory, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China
21178. State Key Laboratory of Oncology in Southern China, Guangzhou, 510060, China
31178. Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China
41178. Department of Pharmacology, College of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, China
Abstract:

Objective

The aim of this study was to use lung cancer targeting binding polypeptide ZS-9 to screen cDNA library of human lung cancer and obtain ZS-9 specific ligand to confirm tumor marker of non small-cell lung cancer.

Methods

Artificially synthesize biotin labeled peptide ZS-9, anchored ZS-9 in the enzyme label plate coupled by avidin, used ZS-9 as probe to screen cDNA library of human lung cancer, after screening, obtained bacteriophage clone specifically binding with anchored polypeptide ZS-9. Extracted plasmid of bacteriophage and performed sequencing after amplified by PCR.

Results

It was demonstrated by bioinformatic analysis on the sequence of ligand binded by lung cancer specific peptide ZS-9 that the ligand was the cytoskeletal protein periplakin on the surface of lung cancer cells, suggesting that periplakin might be a new marker for non-small-cell lung cancer in lung cancer.

Conclusion

Use specific lung cancer binding peptide to screen new tumor marker periplakin in lung cancer and further studies on its biologic functions in genesis and development of lung cancer are still needed.
Keywords:
本文献已被 CNKI SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号